MANNKIND CORP Supply Agreements
13 Contracts & Agreements
- Fourth Amendment to Commercial Supply Agreement, dated December 22, 2022, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on February 23, 2023)
- Third Amendment to Commercial Supply Agreement, dated August 31, 2022, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on February 23, 2023)
- Second Amendment to Commercial Supply Agreement, dated June 15, 2022, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on February 23, 2023)
- First Amendment to Commercial Supply Agreement, dated October 16, 2021, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on November 9, 2021)
- Commercial Supply Agreement, dated August 12, 2021, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on November 9, 2021)
- Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S (Filed With SEC on February 25, 2021)
- Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc (Filed With SEC on February 26, 2019)
- Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc (Filed With SEC on May 9, 2018)
- SECONDAMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on March 16, 2017)
- FIRST AMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on March 16, 2017)
- SUPPLY AGREEMENT (Filed With SEC on November 10, 2014)
- SUPPLY AGREEMENT (Filed With SEC on November 10, 2014)
- Supply Agreement dated December 31, 2004 between MannKind Corporation and Vaupell, Inc (Filed With SEC on February 23, 2005)
